Drugs / Hepatitis B monovalent vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT05705427 Background | Aug 2023 → Nov 2025 | hepatitis B virus infection, infectious embryofetopathy | University of North Carolina, Chapel Hill | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hepatitis B monovalent vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05705427 ↗ |